Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that effective October 17, 2019, the compensation committee of the Company’s board of directors granted options to purchase 142,000 shares of the common stock of the Company to 12 newly hired non-officer employees, 45,000 to one newly hired vice president and 100,000 to one newly hired senior vice president.
October 18, 2019
· 1 min read